L. Pignataro et al. / Tetrahedron: Asymmetry 25 (2014) 844–850
849
drying agents and transferred under nitrogen: THF (Na), Et3N
(CaH2). Dry Et2O and DCM (over molecular sieves in bottles with
crown cap) were stored under nitrogen. Reactions were monitored
by analytical thin-layer chromatography (TLC) using silica gel 60
F254 pre-coated glass plates (0.25 mm thickness). Visualisation
was accomplished by irradiation with a UV lamp and/or staining
with a ceric ammonium molybdate solution. Flash column chro-
matography was performed using silica gel (60 Å, particle size
(282 MHz, CD3OD): d = ꢁ65.0 (s); IR (KBr):
m
= 3270.7, 1644.0,
1416.5, 1382.7, 1277.6, 1129.1, 886.1 cmꢁ1; HRMS (ESIꢁ): m/z
467.08378 [MꢁH]ꢁ (calcd for C22H13N2O3F6: 467.08359).
4.2.2. N1-(3,5-Bis(trifluoromethyl)phenyl)-N2-(3-((11bS)-dinap-
htho [2,1-d:10,20-f][1,3,2]dioxaphosphepin-4-yloxy)phenyl)phth-
alamide L4
(S)-BINOL-PCl (96.4 mg, 0.274 mmol, 1 equiv) was added to a
stirred 0.1 M solution of alcohol 5 (128.3 mg, 0.274 mmol, 1 equiv)
and Et3N (0.115 mL, 83.2 mg, 0.822 mmol, 3 equiv) in THF. The
obtained mixture was stirred overnight and then filtered through
a pad of Celite (rinsing with THF). The solvent was evaporated
under reduced pressure and the crude product was purified by trit-
uration with 4:1 Et2O/DCM, which gave a white solid. Yield:
40–64 lm) as stationary phase, following the procedure by Still
and co-workers.13 Proton NMR spectra were recorded on a spec-
trometer operating at 400.13 MHz. Proton chemical shifts are
reported in ppm (d) with the solvent reference relative to tetra-
methylsilane (TMS) employed as the internal standard (CDCl3
d = 7.26 ppm; CD2Cl2, d = 5.32 ppm; [D]6acetone, d = 2.05 ppm;
CD3OD, d = 3.33 ppm). The following abbreviations are used to
describe spin multiplicity: s = singlet, d = doublet, t = triplet,
q = quartet, m = multiplet, br = broad signal, dd = doublet–doublet,
td = triplet–doublet. 13C NMR spectra were recorded on a 400 MHz
spectrometer operating at 100.56 MHz, with complete proton
decoupling. Carbon chemical shifts are reported in ppm (d) relative
to TMS with the respective solvent resonance as the internal stan-
dard (CDCl3, d = 77.23 ppm; CD2Cl2, d = 54.00 ppm; [D]6acetone,
d = 206.26 ppm and 29.84 ppm; CD3OD, d = 49.05 ppm). 31P NMR
spectra were recorded on a 400 MHz spectrometer operating at
162 MHz, with complete proton decoupling. 31P NMR chemical
shifts are reported in ppm (d) relative to external 85% H3PO4 at
0 ppm (positive values downfield). 19F NMR were recorded on a
300 MHz spectrometer operating at 282 MHz. 19F NMR chemical
shifts are reported in ppm (d) relative to external CFCl3 at 0 ppm
(positive values downfield). The coupling constant values are given
in Hz. Infrared spectra were recorded on a standard FT/IR spec-
trometer. Optical rotation values were measured on an automatic
polarimeter with a 1 dm cell at the sodium D line (k = 589 nm).
High resolution mass spectra (HRMS) were performed on a Fourier
Transform Ion Cyclotron Resonance (FT-ICR) Mass Spectrometer
APEX II and Xmass software (Bruker Daltonics)—4.7 T Magnet
(Magnex) equipped with ESI source, available at CIGA (Centro
Interdipartimentale Grandi Apparecchiature) c/o Università degli
Studi di Milano.
146.1 mg (68%). Mp = 167–168 °C; [a]
20 = +43.3 (c 0.96, acetone);
D
1H NMR (400 MHz, [D]6acetone): d = 10.27 (s, 1H), 9.85 (s, 1H), 8.46
(s, 2H), 8.18 (d, 3J(H,H) = 8.8 Hz, 1H), 8.09 (d, 3J(H,H) = 8.2 Hz, 1H),
8.03 (d, 3J(H,H) = 8.8 Hz, 1H), 8.01 (d, 3J(H,H) = 8.2 Hz, 1H), 7.89 (s,
1H), 7.81–7.74 (m, 2H), 7.70 (s, 1H), 7.67 (d, 3J(H,H) = 8.8 Hz, 1H),
7.62–7.48 (m, 6H), 7.39–7.32 (m, 5H), 7.00 (dd, 3J(H,H) = 8.1 Hz,
4J(H,H) = 2.0 Hz, 1H); 13C NMR (100 MHz, [D]6acetone): d = 168.5,
167.6, 152.6, 148.5, 147.8, 142.2, 141.8, 137.4, 137.1, 133.6,
133.3, 132.8, 132.6 (q, 2J(C,F) = 33.0 Hz), 131.8, 131.4, 131.2,
131.0, 131.0, 129.6, 129.4, 128.9, 127.5, 127.4, 127.4, 127.3,
126.4, 126.1, 125.1, 124.4 (q, 2J(C,F) = 272.2 Hz), 123.5, 122.7,
122.5, 120.4, 117.4, 116.7, 116.6, 116.5, 112.8; 31P NMR
(162 MHz, [D]6acetone): d = 144.6 (s); 19F NMR (282 MHz, [D]6ace-
tone): d = ꢁ64.0 (s); IR (KBr):
m = 3248.5, 3057.1, 1648.8, 1585.7,
1472.4, 1438.5, 1382.7, 1277.6, 1133.9, 948.8 cmꢁ1; HRMS (ESI+):
m/z 805.12915 [M+Na]+ (calcd for C42H25N2O5F6PNa: 805.12975).
4.3. Allylic amination cyclisation experiments
4.3.1. General procedure for the ligand screening in the allylation
of substrate (E)-1a (Table 1)
In each vessel of a carousel multireactor at 25 °C, [Pd2(dba)3-
ꢀCHCl3] was added as a 2.781 mM DCM stock solution (0.2 mL,
0.556
(2.336
mixture was stirred for 10 min and then a 0.222 M DCM solution
of substrate (E)-1a (0.1 mL, 22.2 mol, 1 equiv) was added. The
lmol, 0.025 equiv), followed by the selected ligand
lmol, 0.105 equiv) and by 1.3 mL of DCM. The resulting
The synthesis and characterisation of ligands L1-3/L5-18 have
been reported elsewhere.8 Ligands 6 and 7 are known com-
pounds,14 that we prepared according to a published procedure.15
Chlorophosphite (S)-BINOL-PCl was prepared from (S)-BINOL on a
gram scale according to a literature procedure.16 Substrates (Z)-
1a, (E)-1a, (E)-1b and (Z)-2a were prepared following published
procedures.3b,c
l
reaction mixture was stirred overnight (conversion was monitored
by TLC with 7:3 hexane/AcOEt eluent), then the solvent was
quickly evaporated. The conversion was determined by proton
NMR analysis of the residue.17 Reaction product P13b was purified
by flash chromatography (eluent: DCM), and then analysed by chi-
ral HPLC for determining the enantiomeric excess (column: Daicel
Chiralpak AD-H; eluent: 8:2 hexane/i-PrOH; flow: 0.8 mL/min;
k = 210 nm; tR = 23.5 min [(S)-enantiomer] and 33.4 min [(R)-enan-
tiomer]18). Rf 0.29 (DCM). 1H NMR of product P13b (400 MHz, CD2-
Cl2): d = 7.64 (d, 3J(H,H) = 7.5 Hz, 2H), 7.22 (d, 3J(H,H) = 7.5 Hz, 2H),
6.53 (s, 1H), 6.47 (s, 1H), 5.89 (ddd, 3J(H,H) = 17.0, 10.2, 5.8 Hz, 1H),
5.40 (d, 3J(H,H) = 5.8 Hz, 1H), 5.15 (d, 3J(H,H) = 10.2 Hz, 1H), 5.05
(d, 3J(H,H) = 17.0 Hz, 1H), 3.83 (dd, 3J(H,H) = 13.7, 6.0 Hz, 1H),
3.77 (s, 3H), 3.75 (s, 3H), 3.30 (m, 1H), 2.64 (m, 1H), 2.50 (m,
1H), 2.37 (s, 3H).
4.2. Synthesis of ligand L4
4.2.1. N1-(3,5-Bis(trifluoromethyl)phenyl)-N2-(3-hydroxyphenyl)
phthalamide 5
Phthalisoimide 48 (184.2 mg, 0.513 mmol, 1 equiv) was added
to
a
stirred 0.11 M solution of 3-aminophenol (67.2 mg,
0.6154 mmol, 1.2 equiv) in THF. The mixture was stirred overnight
at rt. The mixture was diluted with AcOEt (triple volume with
respect to THF) and washed three times with 1 M HCl. The organic
phase was dried over Na2SO4 and evaporated. Purification by flash
chromatography (9:1 and then 8:2 DCM/AcOEt) afforded the prod-
uct as a white solid. Yield: 240 mg (quantitative). mp = 134–
135 °C; 1H NMR (400 MHz, CD3OD): d = 8.32 (s, 2H), 7.77 (m, 2H),
7.68 (s, 1H), 7.67 (m, 2H), 7.27 (t, 4J(H,H) = 1.6 Hz, 1H), 7.14 (t,
3J(H,H) = 8.1 Hz, 1H), 7.04 (d, 3J(H,H) = 8.1 Hz, 1H), 6.59 (dd,
3J(H,H) = 8.1 Hz, 4J(H,H) = 1.6 Hz, 1H); 13C NMR (100 MHz, CD3OD):
d = 170.1, 169.4, 158.9, 142.1, 140.8, 137.6, 137.0, 133.2 (q,
2J(C,F) = 33.3 Hz), 131.8, 131.6, 130.5, 129.1, 129.1, 124.7 (q,
2J(C,F) = 272.0 Hz), 121.1, 117.9, 113.2, 112.8, 109.1; 19F NMR
4.3.2. General procedure for the next catalytic tests (Tables 2–4)
In each vessel of a carousel multireactor at 25 °C, [Pd2(dba)3-
ꢀCHCl3] was added as a 2.781 mM DCM stock solution (0.2 mL,
0.556 lmol, 0.025 equiv). Next, DCM was evaporated off under
high vacuum and then the residue was re-dissolved in the selected
solvent (0.5 mL). Ligand L4 (1.8 mg, 2.336 mol, 0.105 equiv) was
l
added, followed by 1 mL of the selected solvent. The resulting mix-
ture was stirred for 10 min and then the temperature was set to
the selected value (if different from 25 °C). A 0.222 M DCM solution